Language selection

Search

2013-01-03 - Female - 9 Years old

492728

Adverse reaction report number 492728
Latest AER version number 0
Market authorization holder AER number ALL1201206508
Initial received date 2013-01-03
Latest received date 2013-01-03
Age 9 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral30 Milligram Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral15 Milligram Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Date modified: